PJ

Paul John

Active Director Director DIN 01822133
DIN 01822133 First appointment Feb 2006 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2006
Shareholding value Locked Premium profile

About Paul John

Paul John has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Cnidus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01822133
Primary Designation Director
First Appointment 14 Feb 2006
Oldest Company Age 20 yrs

Current companies

Company Designation Appointment Founded Status
Cnidus Pharma Private Limited U24232KL2006PTC019188
Director 14 Feb 2006 2006 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cnidus Pharma Private Limited
Premium access

Shareholding and investment profile for Paul John

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paul John

Paul John has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Cnidus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Paul John is associated with 1 company as Director.

Paul John has expertise in General Business.

Paul John has 20 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available